Published in
Impact Journals, Oncotarget, 2(6), p. 1315-1326, 2014
Links
- ORCID
- Impact Journals
- [www.ncbi.nlm.nih.gov] | PDF
- [publications.rwth-aachen.de]
- [www.ncbi.nlm.nih.gov] | PDF
- [europepmc.org] | PDF
Tools
PIK3CA mutations in non-small cell lung cancer (NSCLC): Genetic heterogeneity, prognostic impact and incidence of prior malignancies
Journal article published in 2014 by
Matthias Scheffler 
,
Marc Bos,
Masyar Gardizi,
Katharina König,
Sebastian Michels,
Jana Fassunke,
Carina Heydt,
H. Kuenstlinger,
Helen Künstlinger,
Michaela Ihle,
Frank Ueckeroth,
Kerstin Albus,
Monika Serke,
K. Toepelt,
Ulrich Gerigk
and other authors.
,
Marc Bos,
Masyar Gardizi,
Katharina König,
Sebastian Michels,
Jana Fassunke,
Carina Heydt,
H. Kuenstlinger,
Helen Künstlinger,
Michaela Ihle,
Frank Ueckeroth,
Kerstin Albus,
Monika Serke,
K. Toepelt,
Ulrich Gerigk
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Preprint: archiving forbidden
Postprint:
archiving forbidden
Data provided by 
Abstract
Background: Somatic mutations of the PIK3CA gene have been described in non-small cell lung cancer (NSCLC), but limited data is available on their biological relevance. This study was performed to characterize PIK3CA-mutated NSCLC clinically and genetically.